PROCESS FOR DETECTING PROSTATE CANCER BIOMARKERS
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Sep 7, 2017
app pub date -
Jan 21, 2017
filing date -
Mar 3, 2016
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
A process for detecting prostate cancer biomarkers includes: subjecting seminal plasma fluid to western blot analysis; identifying a first prostate specific antigen (PSA) subform in the seminal plasma fluid, based on the western blot analysis; identifying a second PSA subform in the seminal plasma fluid, based on the western blot analysis; and quantifying a first amount of the first PSA subform and a second amount of the second PSA subform in the seminal plasma fluid to detect prostate cancer biomarkers in a subject from which the seminal plasma fluid was provided.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully